Cough Assist Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Type (Automatic v/s Manual), by Choice of Delivery (Face Mask, Mouthpiece, Adapter), by End User (Hospitals & Clinics, Ambulatory Care Settings, Homecare, Others), by Region and Competition

Global cough assist device market is expected to register a steady CAGR during the forecast period, 2024-2028. This can be ascribed to increasing research and development activities along with technological advancement which will further bring the different opportunities for the growth of the cough assist device market during the forecast period. Additionally, increasing number of elderly patients suffering from various kinds of respiratory problems would lead to transformation in healthcare delivery and create a larger demand for advanced device for treatment of different problems. Besides, increasing cases of lower respiratory problem is further expected to create new prospects for growth of cough assist devices market. Furthermore, increasing research and development by different academic & research institutions and medical device manufacturers to create innovative products to cure the chronic breathing problem and launch of various cough assist devices across the globe is further expected to drive the market during the forecast period. A cough assist device works by using a combination of positive and negative pressure to inflate and deflate the lungs. The device consists of a mask that fits over the patient's nose and mouth, a handheld controller, and a tube that connects the mask to the controller. The process can be repeated several times to help the patient clear as much mucus as possible from their airways. Some devices also use HFCWO technology to create vibrations that help to loosen mucus and make it easier to cough up. Cough assist devices can be expensive, which may limit their accessibility for some patients. Additionally, some insurance companies may not cover the cost of these devices, making them even less accessible for those who need them. While awareness of cough assist devices is growing, many patients and healthcare providers may still be unaware of the benefits they offer. This can make it difficult for patients to access these devices and can also lead to a lack of reimbursement from insurance companies. Some cough assist devices can be complex to operate, requiring patients and caregivers to undergo training before using them. This can be a barrier to access for some patients who may find the devices too difficult to use. Cough assist devices require ongoing maintenance to ensure they continue to function properly. This can be a challenge for patients who may not have the resources or knowledge to perform this maintenance themselves. In rare cases, cough assist devices can cause adverse effects such as discomfort, bleeding, or injury. Healthcare providers must carefully monitor patients using these devices to ensure they are being used safely and effectively.

Increasing Prevalence of Chronic Breathing Problem

Substantial increase in number of patients suffering from chronic breathing disorders such as pulmonary disease, asthma and lung cancer and rapid technological advancements in medical devices are major factors expected to drive the growth of global cough assisted devices market. According to RnCeus, as of 2020, more than 25 million people in the United States had asthma. Approximately 14.8 million adults have been diagnosed with COPD, and approximately 12 million people have not yet been diagnosed. Product advancement activities by major players through approach toward introduction of innovative solutions are factors expected to impact the growth of target market. Easy availability of alternative options along with lack of awareness in developing economies regarding the benefits of the devices are acting as market restraints for the growth of the cough assist devices. Chronic Lower Respiratory Disease (CLRD) has resulted in 49.2 deaths per 100,000 adults, making it the fourth leading cause of death. Mortality rates per 100,000 were 0.2, 2.2, and 45.8, respectively, for bronchitis, emphysema, and other non-asthma CLRD. According to national cancer institute, in 2021, the total number of new lung and bronchus cancer cases were 236,740 in the United States. Between 2005 and 2010, an average of 130,659 Americans (74,300 men and 56,359 women) died of smoking-attributable lung cancer each year. Exposure to second-hand smoke causes approximately 7,330 lung cancer deaths among non-smokers every year. The growing prevalence of respiratory disorders such as COPD, asthma, and cystic fibrosis is one of the primary drivers of the cough assist device market. These conditions can make it difficult for patients to clear their airways, leading to increased risk of respiratory infections. As the global population ages and the prevalence of respiratory disorders increases, the demand for cough assist devices is expected to grow. Governments and healthcare systems around the world are placing greater emphasis on preventative care and chronic disease management, leading to increased spending on healthcare. As a result, the use of cough assist devices is becoming more common as healthcare providers look for ways to improve patient outcomes and reduce healthcare costs. As awareness of the benefits of cough assist devices grows, more patients are seeking out these devices to improve their respiratory health. Healthcare providers are also becoming more aware of the benefits of cough assist devices and are recommending them to their patients. This increased awareness is helping to expand the market for cough assist devices. As the global population ages, the prevalence of respiratory disorders and other chronic conditions is expected to increase. This is likely to drive demand for cough assist devices as more patients require assistance to clear their airways and prevent respiratory infections.

Increasing Air Pollution

Rising exposure of high pollution levels cause breath and coughing problem. Air quality affects everyone, but some people are more at risk than others. Children and older adults, individuals with pre-existing cardiovascular or respiratory diseases, or genetic polymorphisms are at increased risk of air pollution-related health effects. This can be exacerbated when our body’s defence mechanisms are impaired. Research is ongoing to identify causal associations of air pollutants with adverse health outcomes, and to uncover plausible biological mechanisms for these effects. Over 20 million people in the U.S., including six million children now gasp for breath due to asthma. Indoor air pollution can lead to detrimental effects on the human health. People who are exposed to indoor air pollutants for long periods are often most at risk to the effects of indoor air pollution and suffering from various respiratory problems. The above-mentioned factors are expected to boost the market during the forecast period. In 2020, global healthcare company Philips acquired respiratory care company BioTelemetry to expand its respiratory care offerings. This acquisition included BioTelemetry's cough assist device, the HT1100, which is designed to help patients with neuromuscular disorders. In 2020, medical device company Hill-Rom entered into a partnership with respiratory therapy company Respirtech to expand its airway clearance portfolio. Similarly, in 2021, cough assist device manufacturer Hayek Medical partnered with respiratory therapy company GCE Healthcare to expand its global reach and improve patient outcomes. Several companies have launched new cough assist devices in recent years, including the Philips CoughAssist T70, the Hill-Rom Monarch Airway Clearance System, and the ResMed Astral Life Support Ventilator. These devices offer improved functionality and ease of use, making them more accessible for patients.

Recent Development

• ResMed Astral Life Support Ventilator, this ventilator was launched by ResMed in 2020 and is designed to provide respiratory support for patients with chronic respiratory conditions, including those who require cough assistance. The device is compact and lightweight, making it easier for patients to use and transport.
• Hill-Rom Monarch Airway Clearance System,this cough assist device was launched by Hill-Rom in 2019 and is designed to help patients with respiratory conditions to clear mucus from their airways. The device uses a combination of positive and negative pressure to mimic a natural cough and is portable, making it more convenient for patients.
• Philips CoughAssist T70,this cough assist device was launched by Philips in 2018 and is designed to help patients with respiratory conditions to clear mucus from their airways. The device uses a combination of positive and negative pressure and has several modes to accommodate different patient needs. It is also equipped with a touch screen interface for ease of use.

Download Free Sample Report

Market Segmentation

Global Cough Assist Device market is segmented on the basis of type, choice of delivery, end user, and region. Based on type, the market is further bifurcated automatic and manual. Based on choice of delivery, the market can be segmented into face mask, mouthpiece, and adapter. Based on End User, the market can be segmented into hospitals & clinics, ambulatory care settings, homecare, and others. On the basis of region, Europe dominated the market among Asia Pacific, North America, Middle East & Africa and South America. In terms of country, North America region, United States dominated the cough assist device market in 2022 and will continue maintaining its dominance through 2028 on account of growing prevalence of various types of respiratory problems wherein these devices are used.

Market Players

Koninklijke Philips N.V., Hillrom Holdings, Inc., Percussionaire Corporation, Dima Italia Srl, United Hayek Industries Inc, McKesson Medical-Surgical Inc., Aetna Inc., International Biophysics Corporation, PARI GmbH, and Air Liquide Medical Systems S.A. are some of the leading players operating in the Global Cough Assist Device Market.

Report Scope:

In this report, global cough assist device market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cough Assist Device Market.

·         Cough Assist Device Market, By Type:

o    Automatic

o    Manual

·         Cough Assist Device Market, By Choice of Delivery:

o    Face Mask

o    Mouthpiece

o    Adapter

·         Cough Assist Device Market, By End User:

o    Hospitals & Clinics

o    Ambulatory Care Settings

o    Homecare

o    Others

·         Cough Assist Device Market, By Region:

o    North America

United States

Canada

Mexico

o    Europe

France

Germany

United Kingdom

Italy

Spain

o    Asia Pacific

China

India

Japan

South Korea

Australia

o   South America

Brazil

Argentina

Colombia

o    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cough Assist Device Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Cough AssistDeviceMarket is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]